173 related articles for article (PubMed ID: 32703544)
61. Bilateral and multifocal Warthin's tumors of parotid glands: PET/CT imaging.
Nguyen VX; Nguyen BD; Ram PC
Clin Nucl Med; 2012 Feb; 37(2):175-7. PubMed ID: 22228345
[TBL] [Abstract][Full Text] [Related]
62. Parotid gland tumours: MR tractography to assess contact with the facial nerve.
Attyé A; Karkas A; Troprès I; Roustit M; Kastler A; Bettega G; Lamalle L; Renard F; Righini C; Krainik A
Eur Radiol; 2016 Jul; 26(7):2233-41. PubMed ID: 26449562
[TBL] [Abstract][Full Text] [Related]
63. [The comparative value of ultrasonography and radiologic study for the diagnosis of parotid tumors].
Scheffer P; Seguin G; Aadil A; Kouadio Koffi D; Attar A; Levy J
Rev Stomatol Chir Maxillofac; 1994; 95(2):136-7. PubMed ID: 8036404
[No Abstract] [Full Text] [Related]
64. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging.
Zhang Z; Song C; Zhang Y; Wen B; Zhu J; Cheng J
Dentomaxillofac Radiol; 2019 Oct; 48(7):20190100. PubMed ID: 31265331
[TBL] [Abstract][Full Text] [Related]
65. Pleomorphic adenoma and adenolymphoma in ultrasonography.
Zajkowski P; Jakubowski W; Białek EJ; Wysocki M; Osmólski A; Serafin-Król M
Eur J Ultrasound; 2000 Sep; 12(1):23-9. PubMed ID: 10996767
[TBL] [Abstract][Full Text] [Related]
66. Warthin's tumor of parotid gland on Tc-99m pertechnetate scintigraphy with lemon juice stimulation: Tc-99m uptake, size, and pathologic correlation.
Miyake H; Matsumoto A; Hori Y; Takeoka H; Kiyosue H; Hori Y; Mori H; Ueyama S; Kashima K
Eur Radiol; 2001; 11(12):2472-8. PubMed ID: 11734943
[TBL] [Abstract][Full Text] [Related]
67. Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results.
Bisdas S; Baghi M; Wagenblast J; Knecht R; Thng CH; Koh TS; Vogl TJ
Eur J Radiol; 2007 Nov; 64(2):258-65. PubMed ID: 17399933
[TBL] [Abstract][Full Text] [Related]
68. [Evaluation of RI scintiscanning to parotid gland tumors].
Shinohara S; Yamamoto E; Tanabe M; Maetani T; Fujiwara K; Kim T
Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):852-8. PubMed ID: 11605225
[TBL] [Abstract][Full Text] [Related]
69. Assessment of parotid masses: which MR pulse sequences are optimal?
Takashima S; Sone S; Takayama F; Maruyama Y; Hasegawa M; Horii A; Yoshida J
Eur J Radiol; 1997 May; 24(3):206-15. PubMed ID: 9232391
[TBL] [Abstract][Full Text] [Related]
70. Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands.
Hisatomi M; Asaumi J; Konouchi H; Yanagi Y; Matsuzaki H; Kishi K
Oral Oncol; 2002 Jun; 38(4):369-72. PubMed ID: 12076701
[TBL] [Abstract][Full Text] [Related]
71. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
Razek AAKA
Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
[TBL] [Abstract][Full Text] [Related]
72. Classification of parotid gland tumors by using multimodal MRI and deep learning.
Chang YJ; Huang TY; Liu YJ; Chung HW; Juan CJ
NMR Biomed; 2021 Jan; 34(1):e4408. PubMed ID: 32886955
[TBL] [Abstract][Full Text] [Related]
73. Parotid gland lesions: separate and combined diagnostic value of conventional MRI, diffusion-weighted imaging and dynamic contrast-enhanced MRI.
Yuan Y; Tang W; Tao X
Br J Radiol; 2016; 89(1060):20150912. PubMed ID: 26892378
[TBL] [Abstract][Full Text] [Related]
74. Differentiation of parotid gland tumors with contrast-enhanced ultrasound.
Fischer T; Paschen CF; Slowinski T; Alkhameri A; Berl JC; Klingebiel R; Thomas A
Rofo; 2010 Feb; 182(2):155-62. PubMed ID: 19862655
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of parotid gland lesions with standard ultrasound, color duplex sonography, sonoelastography, and acoustic radiation force impulse imaging - a pilot study.
Mansour N; Stock KF; Chaker A; Bas M; Knopf A
Ultraschall Med; 2012 Jun; 33(3):283-8. PubMed ID: 22504938
[TBL] [Abstract][Full Text] [Related]
76. Parotid pleomorphic adenomas: delayed CT enhancement.
Lev MH; Khanduja K; Morris PP; Curtin HD
AJNR Am J Neuroradiol; 1998; 19(10):1835-9. PubMed ID: 9874532
[TBL] [Abstract][Full Text] [Related]
77. [Conventional and functional MRI features of parotid Warthin tumor: correlation with clinicopathological findings].
Jia CH; Cao R; Kuai XP; Zhang HQ; Ding QG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Feb; 54(2):94-100. PubMed ID: 30695910
[No Abstract] [Full Text] [Related]
78. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesions of the parotid gland.
Zhu Q; White FH; Tipoe GL
Oral Oncol; 1997 Jan; 33(1):29-35. PubMed ID: 9192550
[TBL] [Abstract][Full Text] [Related]
79. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.
Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y
Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661
[TBL] [Abstract][Full Text] [Related]
80. Carcinoma ex pleomorphic adenoma of the parotid gland.
Kashiwagi N; Murakami T; Chikugo T; Tomita Y; Kawano K; Nakanishi K; Mori K; Tomiyama N
Acta Radiol; 2012 Apr; 53(3):303-6. PubMed ID: 22287150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
